Home LEAP Platform

LEAP Platform

Attention: open in a new window. PDFPrint

 LEISHMANIASIS EAST AFRICA PLATFORM (LEAP)

Founded: 2003 in Khartoum, Sudan
Members: Center for Clinical Research, Kenya; Medical Research Institute, Kenya; Ministry of Health, Kenya; Institute of Endemic Diseases, University of Khartoum, Sudan; Federal Ministry of Health, Sudan; Addis Ababa University, Ethiopia; Gondar University, Ethiopia; Federal Bureau of Health, Ethiopia; Makerere University, Uganda; Ministry of Health, Uganda; Médecins Sans Frontières; i+ Solutions; Institute for OneWorld Health (iOWH); AMC/KIT/University of Slotervaart, Amsterdam, The Netherlands; London School of Hygiene and Tropical Medicine (LSHTM), UK.
  • 50 individual members, representing over 20 institutions
  • Over 1,100 patients enrolled in clinical trials by the end of 2010
  • Approximately 1,000 patients treated outside clinical trials per year

Objectives: The overall aim of the platform is to strengthen clinical research capacity, which is lacking in part due to the remoteness and geographic spread of the patients, most of whom live in the most impoverished regions of Africa. This platform also serves as a base for ongoing educational cooperation between the countries in the East African region and standardization of procedures and practices within the region, as far as is possible within the confines of local regulations. LEAP evaluates, validates, and registers new treatments that address regional needs for VL.
 


Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License